Expanding Level 4 Epilepsy Centers Will Unlock Future Potential

Shared on01 May 25
Fair value Increased 17%

Shared on24 Apr 25
Fair value Decreased 15%

AnalystConsensusTarget has increased shares outstanding growth rate from 0.1% to 0.1%.

Shared on17 Apr 25
Fair value Decreased 2.49%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Increased 3.36%

AnalystConsensusTarget has decreased shares outstanding growth rate from 0.1% to 0.1%.

Shared on02 Apr 25
Fair value Decreased 1.74%